Development and regression of left ventricular hypertrophy
IP Panidis,
MN Kotler,
JF Ren,
GS Mintz,
J Ross,
and
P Kalman
Left ventricular hypertrophy is an important adaptive response to chronic pressure or volume overload of the left ventricle. The different types and the pathophysiologic mechanisms of the development of left ventricular hypertrophy in various disease states are reviewed. Detection of left ventricular hypertrophy may be accomplished by electrocardiography and cardiac angiography. Echocardiography, however, is the most accurate noninvasive method to detect the presence and estimate the severity of increased left ventricular mass. The clinical significance of left ventricular hypertrophy and its prognostic implications in several cardiac diseases associated with hypertrophy are discussed. The critical transition stage from adaptive, compensatory and reversible left ventricular hypertrophy to "pathologic" hypertrophy with impaired left ventricular contractility and irreversible myocardial damage is yet unknown. Recent data are presented that provide evidence of regression of left ventricular hypertrophy after medical treatment of patients with hypertension and after aortic valve replacement in patients with aortic valve disease. The clinical importance of regression of hypertrophy and its effects on long-term prognosis remain to be determined.
This article has been cited by other articles:

|
 |

|
 |
 
J. Boissiere, V. Eder, M.-C. Machet, D. Courteix, and P. Bonnet
Moderate exercise training does not worsen left ventricle remodeling and function in untreated severe hypertensive rats
J Appl Physiol,
February 1, 2008;
104(2):
321 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Asaumi, Y. Kagaya, M. Takeda, N. Yamaguchi, H. Tada, K. Ito, J. Ohta, T. Shiroto, K. Shirato, N. Minegishi, et al.
Protective Role of Endogenous Erythropoietin System in Nonhematopoietic Cells Against Pressure Overload-Induced Left Ventricular Dysfunction in Mice
Circulation,
April 17, 2007;
115(15):
2022 - 2032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Eghtesady, E. Michelfelder, M. Altaye, E. Ballard, R. Hirsh, and R. H. Beekman III
Revisiting Animal Models of Aortic Stenosis in the Early Gestation Fetus
Ann. Thorac. Surg.,
February 1, 2007;
83(2):
631 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
Cardiovasc Res,
January 15, 2007;
73(2):
257 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al.
Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy
Circ. Res.,
December 8, 2006;
99(12):
1411 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Guenzinger, W. B. Eichinger, F. Botzenhardt, S. Bleiziffer, I. Wagner, R. Bauernschmitt, S. M. Wildhirt, and R. Lange
Rest and Exercise Performance of the Medtronic Advantage Bileaflet Valve in the Aortic Position
Ann. Thorac. Surg.,
October 1, 2005;
80(4):
1319 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Gao, H. Kiriazis, X.-L. Moore, X.-H. Feng, K. Sheppard, A. Dart, and X.-J. Du
Regression of pressure overload-induced left ventricular hypertrophy in mice
Am J Physiol Heart Circ Physiol,
June 1, 2005;
288(6):
H2702 - H2707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Le Bret, J. M. Lupoglazoff, N. Borenstein, G. Fromont, F. Laborde, J. Bachet, and P. Vouhe
Cardiac "Fitness" Training: An Experimental Comparative Study of Three Methods of Pulmonary Artery Banding for Ventricular Training
Ann. Thorac. Surg.,
January 1, 2005;
79(1):
198 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaudino, F. Alessandrini, F. Glieca, N. Luciani, C. Cellini, C. Pragliola, M. Morelli, C. Canosa, G. Nasso, and G. Possati
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?
Eur. Heart J.,
January 1, 2005;
26(1):
51 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Iemitsu, T. Miyauchi, S. Maeda, S. Sakai, T. Kobayashi, N. Fujii, H. Miyazaki, M. Matsuda, and I. Yamaguchi
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2001;
281(6):
R2029 - R2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Christakis, C. D. Joyner, C. D. Morgan, S. E. Fremes, K. J. Buth, J. Y. Sever, V. Rao, K. P. Panagiotopoulos, P. M. Murphy, and B. S. Goldman
Left Ventricular Mass Regression Early After Aortic Valve Replacement
Ann. Thorac. Surg.,
October 1, 1996;
62(4):
1084 - 1089.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. R. Liebson, G. A. Grandits, S. Dianzumba, R. J. Prineas, R. H. Grimm Jr, J. D. Neaton, and J. Stamler
Comparison of Five Antihypertensive Monotherapies and Placebo for Change in Left Ventricular Mass in Patients Receiving Nutritional-Hygienic Therapy in the Treatment of Mild Hypertension Study (TOMHS)
Circulation,
February 1, 1995;
91(3):
698 - 706.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald
The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Arch Intern Med,
February 1, 1991;
151(2):
250 - 259.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Levy, R. J. Garrison, D. D. Savage, W. B. Kannel, and W. P. Castelli
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort: The Framingham Heart Study
Ann Intern Med,
January 15, 1989;
110(2):
101 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. LEVY, K. M. ANDERSON, D. D. SAVAGE, W. B. KANNEL, J. C. CHRISTIANSEN, and W. P. CASTELLI
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors: The Framingham Heart Study
Ann Intern Med,
January 1, 1988;
108(1):
7 - 13.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders
Ann Intern Med,
November 1, 1986;
105(5):
714 - 729.
[Abstract]
[PDF]
|
 |
|
|